Inventor · disambiguated record
Jack Lin
Also filed as: LIN JACK · LIN JACK JONG-JYE
28 granted patents·9 pending applications·802 citations·filing 2004–2024
97Inventor score
Top patents by PatentIndex Score
37 records- 0198US7476746B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted Jan 13, 2009·61 cites·16 claims
- 0297US9771369B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Granted Sep 26, 2017·24 cites·18 claims
- 0397US7723374B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted May 25, 2010·54 cites·11 claims
- 0497US7572806B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted Aug 11, 2009·59 cites·5 claims
- 0597US7491831B2PPAR active compoundsPLEXXIKON INC·Filed 2007·Granted Feb 17, 2009·56 cites·17 claims
- 0697US7348338B2PPAR active compoundsPLEXXIKON INC·Filed 2004·Granted Mar 25, 2008·79 cites·9 claims
- 0796US9776998B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2016·Granted Oct 3, 2017·20 cites·12 claims
- 0896US9440969B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Sep 13, 2016·40 cites·19 claims
- 0996US8367828B2PPAR active compoundsPLEXXIKON INC·Filed 2010·Granted Feb 5, 2013·54 cites·7 claims
- 1095US9814714B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 14, 2017·22 cites·31 claims
- 1195US9718847B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2014·Granted Aug 1, 2017·33 cites·21 claims
- 1295US9624213B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA·Filed 2012·Granted Apr 18, 2017·38 cites·4 claims
- 1395US8053463B2PPAR active compoundsPLEXXIKON INC·Filed 2008·Granted Nov 8, 2011·45 cites·8 claims
- 1495US7531568B2PPAR active compoundsPLEXXIKON INC·Filed 2005·Granted May 12, 2009·51 cites·12 claims
- 1595US7202266B2PPAR active compoundsPLEXXIKON INC·Filed 2004·Granted Apr 10, 2007·65 cites·54 claims
- 1694US10160755B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 25, 2018·15 cites·14 claims
- 1794US9994567B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2017·Granted Jun 12, 2018·14 cites·7 claims
- 1893US9676748B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 13, 2017·23 cites·20 claims
- 1992US11739088B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2021·Granted Aug 29, 2023·2 cites·14 claims
- 2092US9938273B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Apr 10, 2018·17 cites·43 claims
- 2188US10301280B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 28, 2019·6 cites·21 claims
- 2287US10160747B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 25, 2018·8 cites·25 claims
- 2385US2025195516A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2024·Application pending·0 cites
- 2484US10577366B2Crystalline forms of a compound that inhibits bromodomainPLEXXIKON INC·Filed 2018·Granted Mar 3, 2020·4 cites·16 claims
- 2584US10519177B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted Dec 31, 2019·4 cites·22 claims
- 2684US10227357B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Mar 12, 2019·7 cites·7 claims
- 2783US12076322B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2022·Granted Sep 3, 2024·0 cites·7 claims
- 2879US12435086B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2023·Granted Oct 7, 2025·0 cites·11 claims
- 2977US11337976B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 24, 2022·1 cites·10 claims
- 3066US2025282759A1Polymorphic and salt forms of the autotaxin inhibitor cudetaxestatSABRE THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 3149US2008221127A1Ppar active compoundsPLEXXIKON INC·Filed 2008·Application pending·0 cites
- 3247US2012015966A1Ppar active compoundsLIN JACK·Filed 2011·Application pending·0 cites
- 3346US2011183988A1Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Application pending·0 cites
- 3445US2008234349A1PPAR active compoundsLIN JACK·Filed 2006·Application pending·0 cites
- 3545US2008249137A1PPAR active compoundsLIN JACK·Filed 2006·Application pending·0 cites
- 3645US2007072904A1PPAR active compoundsLIN JACK·Filed 2006·Application pending·0 cites
- 3743US2006135540A1PPAR active compoundsLIN JACK·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jack Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →